THE MBL77 DIARIES

mutations specified the fact that, as described below, CLL therapy relies around the existence or absence of these mutations. The existing consensus is always that, besides clonal mutations, subclonal mutations using a variant allelic frequency ranging from five to ten% (and therefore below the brink of detection by conventional molecular procedure